Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusion

Biology Bulletin

Volumn 32, Issue 4, 2005, Pages 375-380

  Maslov, L N ^a,b   Lishmanov, A Yu ^b   Budankova, E V ^b   Stakheev, D L ^a   Solenkova, N V ^a   Barzakh, E I ^b   Oeltgen, P R ^c   Gross, G J ^d   Chang, W S ^e  

^a TOMSK STATE PEDAGOGICAL UNIVERSITY   (Russian Federation)

^b CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Sanofi Research Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23844487814     PISSN: 10623590     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10525-005-0115-1     Document Type: Article

References (41)

1. Bergey, J.L. and Beil, M.E., Antiarrhythmic Evaluation of Naloxone against Acute Coronary Occlusion-Induced Arrhythmias in Pigs, Eur. J. Pharmacol., 1983, vol. 90, pp. 427-431.
2. Birch, P.J., Hayes, A.G., Sheehan, M.J., and Tyers, M.B., Norbinaltorphimine: Antagonist Profile at Opioid Receptors, Eur. J. Pharmacol., 1987, vol. 144, pp. 405-408.
3. Butelman, E.R., Negus, S.S., Gatch, M.B., Chang, K.-J., and Woods, J.H., BW373U86, a δ-Opioid Receptor Agonist, Reverses Bradykinin-Induced Thermal Allodynia in Rhesus Monkeys, Eur. J. Pharmacol., 1995, vol. 277, pp. 285-287.
4. Caldwell, R.W., Nagarajan, R., Chryssanthis, A., and Tuttle, R.R., Actions of the Opioid Antagonist, Nalmefene, and Congers on Reperfusion Cardiac Arrhythmias and Regional Left Coronary Blood Flow, Pharmacol., 1990, vol. 41, pp. 161-166.
5. Crook, T.J., Kitchen, I., and Hill, R.G., Effects of the δ-Opioid Receptor Antagonist Naltrindole on Antinociceptive Responses To Selective δ-Agonists in Post-Weanling Rats, Br. J. Pharmacol., 1992, vol. 107, pp. 573-576.
6. Dhawan, B.N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P.B., Portoghese, P.S., and Hamon, M., International Union of Pharmacology. XII. Classification of Opioid Receptors, Pharmacol. Rev., 1996, vol. 48, no. 4, pp. 567-592.
7. Fagbemi, O., Lepran, I., and Parratt, J.R., Naloxone Inhibits Early Arrhythmias Resulting from Coronary Ligation, Brit. J. Pharmacol., 1982, vol. 76, pp. 504-506.
8. Fryer, R.M., Hsu, A.K., Nagase, H., and Gross, G.J., Opioid-Induced Cardioprotection against Myocardial Infarction and Arrhythmias: Mitochondrial versus Sarcolemmal ATP-Sensitive Potassium Channels, J. Pharmacol. Exp. Ther., 2000, vol. 294, no. 2, pp. 451-457.
9. Horan, P.J., de Costa, B.R., Rice, K., Haaseth, R.C., Hruby, V.J., and Porreca, F., Differential Antagonism of Bremazocine- and U69,593-Induced Antinociception by Quadazocine: Further Functional Evidence of Opioid Receptor Multiplicity in the Mouse, J. Pharmacol. Exp. Ther., 1993, vol. 266, no. 2, pp. 926-933.
10. Huang, X.D., Lee, A.Y.S., and Wong, T.M., Naloxone Inhibits Arrhythmias Induced by Coronary Artery Occlusion and Reperfusion in Anaesthetized Dogs, Br. J. Pharmacol., 1986, vol. 87, pp. 475-477.
11. Iyengar, S., Kim, H.S., and Wood, P.L., Effects of Kappa Opiate Agonists on Neurochemical and Neuroendocrine Indices: Evidence for Kappa Receptor Subtypes, Life Sci., 1986, vol. 39, pp. 637-644.
12. Kramer, T.H., Shook, J.E., Kazmierski, W., Ayres, E.A., Wire, W.S., Hruby, V.J., and Burks, T.F., Novel Peptidergic Opioid Antagonists: Pharmacological Characterization in vitro and in vivo, J. Pharmacol. Exp. Ther., 1989, vol. 249, no. 2, pp. 544-551.
13. Lishmanov, Yu.B., Maslov, L.N., and Rais, K., Blood-Brain Barrier Permeability for the Ligands of Opioid Receptors, Eksper. Klin. Farmakol., 2002a, vol. 65, no. 4, pp. 71-77.
14. Lishmanov, Yu.B. and Maslov, L.N., Endogenous Opioid System and Resistance of the Heart against Arrhythmogenic Influences, Kardiol., 2002b, no. 3, pp. 51-57.
15. Lishmanov, Yu.B. and Maslov, L.N., The Opiatergic Link between the Antiarrhythmic Effect of Adaptation and Hypoxia in the Model of Ischemia and Reperfusion in Vivo, Patol. Fiziol. Eksp. Ter., 2003c, no. 1, pp. 2-10.
16. Lishmanov, Yu.B., Naryzhnaya, N.V., Krylatov, A.V., Maslov, L.N., Bogomaz, S.A., Ugdyzhekova, D.S., Gross, G.Dzh., and Stefano, Dzh.B., The Role of Opiate Receptors and ATP-Dependent Potassium Channels of Mitochondria in the Formation of Myocardial Adaptive Resistance to the Arrhythmogenic Effect of Ischemia and Reperfusion, Izv. Akad. Nauk, Ser. Biol., 2003, no. 6, pp. 720-727.
17. 6-Enkephalin and Its Possible Mechanism, J. Cardiol., 1993, vol. 40, no. 2, pp. 89-94.
18. Maslov, L.N., Krylatov, A.V., and Lishmanov, Yu.B., The Anti-Arrhythmic Activity of Agonists of the Peripheral μ-Opiate Receptors, Eksperim. Klin. Farmakol., 1999, vol. 62, no. 3, pp. 28-31.
19. Maslov, L.N., Lishmanov, Yu.B., Kalo, Dzh., Ma, L., and Lambert, D.Dzh., Peripheral Effects of Ligands of ORL1 Receptors, Eksperim. Klin. Farmakol., 2003a, vol. 66, no. 6, pp. 64-73.
20. Maslov, L.N., Lishmanov, Yu.B., Kalo, Dzh., and Ma, L., Central Effects of Ligands of ORL1 Receptors, Eksperim. I Klin. Farmakol., 2003b, vol. 66, no. 5, pp. 59-68.
21. Maslov, L.N., Lishmanov, Yu.B., Solenkova, N.V., Gross, G.J., Stefano, G.B., and Tam, S.W., Activation of Peripheral Delta Opioid Receptors Eliminates Cardiac Electrical Instability in a Rat Model of Post-Infarction Cardiosclerosis via Mitochondrial ATP-Dependent K Channels, Life Sci., 2003c, vol. 73, no. 7, pp. 947-952.
22. Maslov, L.N., Lishmanov, Yu.B., and Smagin, G.N., Opioidnye retseptory. Sostoyanie problemy i perspektivy, Eksperim. I Klin. Farmakol., 2002, vol. 65, no. 2, pp. 70-75.
23. Mikhailova, S.D., Storozhakov, G.I., Bebyakova, N.A., and Semushkina, T.M., Mechanism of the Protective Effect of Dalargin on Development of Ischemic Heart Arrhythmias, Byull. Eksp. Biol. Med., 1996, vol. 122, no. 8, pp. 176-178.
24. Mikhailova, S.D., Storozhakov, G.I., Bebyakova, N.A., and Semushkina, T.M., The Role of the Vagus Nerve in the Anti-Arrhythmic Effect of DAGO in Acute Myocardial Ischemia, Byull. Eksp. Biol. Med., 1997, vol. 124, no. 10, pp. 377-379.
25. Milne, R.J., Coddington, J.M., and Gamble, G.D., Quaternary Naloxone Blocks Morphine Analgesia in Spinal But Not Intact Rats, Neurosci. Let., 1990, vol. 11, pp. 259-264.
26. Murphy, D.B. and Murphy, M.B., Opioid Antagonist Modulation of Ischemia-Induced Ventricular Arrhythmias: a Peripheral Mechanism, J. Cardiovasc. Pharmacol., 1999, vol. 33, pp. 122-125.
27. Negus, S.S., Burke, T.F., Medzihradsky, F., and Woods, J.H., Effects of Opioid Agonists Selective for Mu, Kappa and Delta Opioid Receptors on Schedule-Controlled Responding in Rhesus Monkeys: Antagonism by Quadazocine, J. Pharmacol. Exp. Ther., 1993, vol. 267, no. 2, pp. 896-903.
28. Parratt, J.R. and Sitsapesan, R., Stereospecific Antiarrhythmic Effect of Opioid Receptor Antagonist in Myocardial Ischemia, Br. J. Pharmacol., 1986, vol. 87, pp. 621-622.
29. Portoghese, P.S., Lipkowski, A.W., and Takemori, A.E., Binaltorphimine and Norbinaltorphimine, Potent and Selective - Opioid Receptor Antagonists, Life Sci., 1987, vol. 40, pp. 1287-1291.
30. 1 Opioid Receptor Agonists and Antagonists, J. Med. Chem., 1993, vol. 36, no. 17, pp. 2572-2574.
31. Roques, B.P., Gacel, G., Dauge, V., Baamonde, A., Calenco, G., Turcaud, S., Coric, P., and Fournie-Zaluski, M.C., Novel Approaches in the Development of New Analgesics, Neurophysil. Clin., 1990, vol. 20, pp. 369-387.
32. Russell, D.C., Lawrie, J.S., Riemersma, R.A., and Oliver, M.F., Mechanisms of Phase 1a and 1b Early Ventricular Arrhythmias during Acute Myocardial Ischemia in the Dog, Am. J. Cardiol., 1984, vol. 53, pp. 307-312.
33. Sarne, Y., Flitstein, A., and Oppenheimer, E., Anti-Arrhythmic Activities of Opioid Agonists and Antagonists and Their Stereoisomers, Br. J. Pharmacol., 1991, vol. 102, pp. 696-698.
34. Shook, J.E., Pelton, J.T., Kazmierski, W., Lemcke, P.K., Villar, R.G., Hruby, V.J., and Burks, T.F., A Cyclic Somatostatin Analog That Precipitates Withdrawal in Morphine-Dependent Mice, NIDA Research Monograph Series, 1986, vol. 76, pp. 295-301.
35. Sitsapesan, R. and Parratt, J.R., The Effects of Drugs Interacting with Opioid Receptors on the Early Ventricular Arrhythmias Arising from Myocardial Ischaemia, Br. J. Pharmacol., 1989, vol. 97, no. 3, pp. 795-800.
36. Sofuoglu, M., Portoghese, P.S., and Takemori, A.E., Differential Antagonism of Delta Opioid Agonists by Naltrindole and Its Benzofuran Analog (NTB) in Mice: Evidence for Delta Opioid Receptor Subtypes, J. Pharmacol. Exp. Ther., 1991, vol. 257, pp. 676-680.
37. 1 Opioid Receptor Antagonist in the Mouse Spinal Cord, Life Sci., 1993, vol. 52, no. 8, pp. 769-775.
38. Takemori, A.E., Sultana, M., Nagase, H., and Portoghese, P.S., Agonist and Antagonist Activities of Ligands Derived from Naltrexone and Oxymorphone, Life Sci., 1992, vol. 50, no. 20, pp. 1491-1495.
39. Ward, S.J., Porthoghese, P.S., and Takemori, A.E., Pharmacological Characterization in Vivo of the Novel Opiate, β-Funaltrexamine, J. Pharmacol. Exp. Ther., 1982, vol. 220, no. 3, pp. 494-498.
40. Ward, S.J., Fries, D.S., Larson, D.L., Porthoghese, P.S., and Takemori, A.E., Opioid Binding Characteristics of the Non-Equilibrium Antagonist β-Funaltrexamine (β-FNA), Eur. J. Pharmacol., 1985, vol. 107, pp. 323-330.
41. Witt, K.A., Huber, J.D., Egleton, R.D., and Davis, T.P., Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect, J. Pharmacol. Exp. Ther., 2000, vol. 295, no. 3, pp. 972-978.